DIA461.97+6.08 1.33%
SPY655.38+6.81 1.05%
QQQ588.00+6.67 1.15%

12 Health Care Stocks Moving In Thursday's After-Market Session

Benzinga·02/19/2026 21:06:05
Listen to the news

Gainers

  • iSpecimen (NASDAQ:ISPC) shares moved upwards by 14.1% to $0.32 during Thursday's after-market session. The market value of their outstanding shares is at $3.0 million.
  • BioAtla (NASDAQ:BCAB) shares increased by 6.51% to $0.17. The company's market cap stands at $10.4 million.
  • Nakamoto (NASDAQ:NAKA) shares moved upwards by 3.94% to $0.26. The company's market cap stands at $170.5 million.
  • Crescent Biopharma (NASDAQ:CBIO) shares moved upwards by 3.58% to $12.15. The market value of their outstanding shares is at $295.9 million.
  • Candel Therapeutics (NASDAQ:CADL) stock rose 3.52% to $6.16. The company's market cap stands at $321.1 million.
  • iTonic Holdings (NASDAQ:ITOC) stock moved upwards by 3.5% to $0.4. The market value of their outstanding shares is at $6.7 million.

Losers

  • GRAIL (NASDAQ:GRAL) stock fell 23.6% to $77.54 during Thursday's after-market session. The market value of their outstanding shares is at $3.9 billion. As per the press release, Q4 earnings came out today.
  • Ardelyx (NASDAQ:ARDX) stock fell 16.92% to $5.6. The company's market cap stands at $1.6 billion. As per the press release, Q4 earnings came out today.
  • PTC Therapeutics (NASDAQ:PTCT) stock declined by 10.28% to $62.72. The market value of their outstanding shares is at $5.5 billion. As per the news, the Q4 earnings report came out today.
  • Travere Therapeutics (NASDAQ:TVTX) shares fell 7.17% to $27.2. The market value of their outstanding shares is at $2.4 billion. As per the news, the Q4 earnings report came out today.
  • Profusa (NASDAQ:PFSA) shares fell 4.15% to $1.62. The company's market cap stands at $2.1 million.
  • Theriva Biologics (AMEX:TOVX) stock declined by 4.1% to $0.21. The company's market cap stands at $6.8 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Contact Us

Contact Number :+852 3852 8500
Monday 7:00 AM - Saturday 9:00 AM (HKT)
Service Email :service@webull.hk
Online Support: Monday - Friday: 9:00 - 16:00; 22:30 - 5:00 (HKT)
Business Cooperation :marketinghk@webull.hk
Risk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language

English

©2026 Webull Securities Limited. All rights reserved.